These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31469551)

  • 21. Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
    Dong L; Sharma NP; Jurban BJ; Smith WL
    J Biol Chem; 2013 Oct; 288(40):28641-55. PubMed ID: 23955344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior.
    Furse KE; Pratt DA; Porter NA; Lybrand TP
    Biochemistry; 2006 Mar; 45(10):3189-205. PubMed ID: 16519514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms 15 R-prostaglandins that inhibit platelet aggregation.
    Giménez-Bastida JA; Boeglin WE; Boutaud O; Malkowski MG; Schneider C
    FASEB J; 2019 Jan; 33(1):1033-1041. PubMed ID: 30096040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products.
    Thuresson ED; Lakkides KM; Smith WL
    J Biol Chem; 2000 Mar; 275(12):8501-7. PubMed ID: 10722687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics simulations of arachidonic acid-derived pentadienyl radical intermediate complexes with COX-1 and COX-2: insights into oxygenation regio- and stereoselectivity.
    Furse KE; Pratt DA; Schneider C; Brash AR; Porter NA; Lybrand TP
    Biochemistry; 2006 Mar; 45(10):3206-18. PubMed ID: 16519515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of prostaglandin stereochemistry at the 15-carbon by cyclooxygenases-1 and -2. A critical role for serine 530 and valine 349.
    Schneider C; Boeglin WE; Prusakiewicz JJ; Rowlinson SW; Marnett LJ; Samel N; Brash AR
    J Biol Chem; 2002 Jan; 277(1):478-85. PubMed ID: 11677234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.
    Lecomte M; Laneuville O; Ji C; DeWitt DL; Smith WL
    J Biol Chem; 1994 May; 269(18):13207-15. PubMed ID: 8175750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of two cyclooxygenase active site residues, Leucine 384 and Glycine 526, that control carbon ring cyclization in prostaglandin biosynthesis.
    Schneider C; Boeglin WE; Brash AR
    J Biol Chem; 2004 Feb; 279(6):4404-14. PubMed ID: 14594816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.
    Akasaka H; Ruan KH
    Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
    Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of rofecoxib bound to human cyclooxygenase-2.
    Orlando BJ; Malkowski MG
    Acta Crystallogr F Struct Biol Commun; 2016 Oct; 72(Pt 10):772-776. PubMed ID: 27710942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1.
    Malkowski MG; Thuresson ED; Lakkides KM; Rieke CJ; Micielli R; Smith WL; Garavito RM
    J Biol Chem; 2001 Oct; 276(40):37547-55. PubMed ID: 11477109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid.
    Harman CA; Rieke CJ; Garavito RM; Smith WL
    J Biol Chem; 2004 Oct; 279(41):42929-35. PubMed ID: 15292194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.
    Blobaum AL; Xu S; Rowlinson SW; Duggan KC; Banerjee S; Kudalkar SN; Birmingham WR; Ghebreselasie K; Marnett LJ
    J Biol Chem; 2015 May; 290(20):12793-803. PubMed ID: 25825493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1 increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells.
    López S; Vila L; Breviario F; de Castellarnau C
    Biochim Biophys Acta; 1993 Sep; 1170(1):17-24. PubMed ID: 7691182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.
    Kuwata H; Hara S
    Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGG2, 11R-HPETE and 15R/S-HPETE are formed from different conformers of arachidonic acid in the prostaglandin endoperoxide H synthase-1 cyclooxygenase site.
    Thuresson ED; Lakkides KM; Smith WL
    Adv Exp Med Biol; 2002; 507():67-72. PubMed ID: 12664566
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.
    Blobaum AL; Marnett LJ
    J Biol Chem; 2007 Jun; 282(22):16379-90. PubMed ID: 17434872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prokaryotic expression, purification and characterization of human cyclooxygenase-2.
    Liao X; Wang W; Fan C; Yang N; Zhao J; Zhang Y; Gao R; Shen G; Xia S; Li G
    Int J Mol Med; 2017 Jul; 40(1):75-82. PubMed ID: 28560423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids.
    Sharma NP; Dong L; Yuan C; Noon KR; Smith WL
    Mol Pharmacol; 2010 Jun; 77(6):979-86. PubMed ID: 20194532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.